#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14772	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2090	700.6	0	.	n	.	0	C451T	SNP	451	451	C	686	686	T	818	T	771	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14772	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2090	700.6	1	SNP	n	C1184T	0	.	.	1184	1184	C	1419	1419	C	896	C	835	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27160	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3668	738.6	0	.	n	.	0	T695C	SNP	695	695	T	1083	1083	C	832	C	785	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27160	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3668	738.6	0	.	n	.	0	T1971C	SNP	1971	1971	T	2359	2359	C	890	C,A	822,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27160	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3668	738.6	1	SNP	n	A2045G	0	.	.	2045	2045	A	2433	2433	A	883	A	830	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27160	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3668	738.6	1	SNP	n	C2597T	0	.	.	2597	2597	C	2985	2985	C	832	C	779	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27160	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3668	738.6	0	HET	.	.	.	A1638G	.	1638	1638	A	2026	2026	A	843	A,G	614,183	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	27160	23S	2890	2890	99.93	23S.l6.c30.ctg.1	3668	738.6	0	HET	.	.	.	G2616A	.	2616	2616	G	3004	3004	G	875	G,A	628,190	.	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2008	folP	855	855	100.0	folP.l15.c30.ctg.1	1642	121.8	1	SNP	p	R229S	1	.	.	685	687	AGC	1065	1067	AGC	211;210;211	A;G;C	198;198;202	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5578	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3448	161.3	1	SNP	p	S91F	1	.	.	271	273	TTC	615	617	TTC	193;194;194	T;T,G;C	180;180,1;179	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5578	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3448	161.3	1	SNP	p	D95G	1	.	.	283	285	GGC	627	629	GGC	202;203;203	G;G;C	184;182;186	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	5578	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3448	161.3	1	SNP	p	G95N	0	.	.	283	285	GGC	627	629	GGC	202;203;203	G;G;C	184;182;186	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
mtrR.WHO_O_01438	mtrR.WHO_O_01438	1	1	27	1874	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1395	133.8	1	SNP	p	G45D	0	.	.	133	135	GGC	487	489	GGC	227;228;225	G,A;G;C	207,1;208;209	mtrR.WHO_O_01438:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	856	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	1076	78.8	0	.	n	.	0	A197.	DEL	197	197	A	565	565	A	199	A	190	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5034	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3002	167.1	1	SNP	p	D86N	0	.	.	256	258	GAC	606	608	GAC	192;191;194	G;A;C	180;179;182	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5034	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3002	167.1	1	SNP	p	S87R	1	.	.	259	261	CGT	609	611	CGT	196;199;199	C;G;T	185;185;185	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5034	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3002	167.1	1	SNP	p	R87W	0	.	.	259	261	CGT	609	611	CGT	196;199;199	C;G;T	185;185;185	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5034	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3002	167.1	1	SNP	p	R87I	0	.	.	259	261	CGT	609	611	CGT	196;199;199	C;G;T	185;185;185	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	5034	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3002	167.1	1	SNP	p	S88P	0	.	.	262	264	TCC	612	614	TCC	199;198;197	T;C;C	186;184;187	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4544	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2667	169.9	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1514	1516	GGC	239;235;232	G;G;C	223;219;215	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	4192	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2385	175.0	1	SNP	p	A311V	0	.	.	931	933	GCC	1233	1235	GCC	249;251;248	G;C;C	230;231;230	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4192	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2385	175.0	1	SNP	p	I312M	1	.	.	934	936	ATG	1236	1238	ATG	248;251;251	A;T;G,T	232;233;230,1	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4192	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2385	175.0	1	SNP	p	T316P	0	.	.	946	948	ACC	1248	1250	ACC	251;250;247	A;C;C	227;227;225	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4192	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2385	175.0	1	SNP	p	V316T	1	.	.	946	948	ACC	1248	1250	ACC	251;250;247	A;C;C	227;227;225	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4192	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2385	175.0	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1749	1751	ACC	224;225;227	A,T;C;C	205,1;210;213	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4192	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2385	175.0	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1803	1805	GCG	228;227;227	G;C;G	214;216;215	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4192	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2385	175.0	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1803	1805	GCG	228;227;227	G;C;G	214;216;215	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4192	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2385	175.0	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1926	1928	GGT	175;175;176	G;G;T	162;163;161	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4192	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2385	175.0	1	SNP	p	G545S	1	.	.	1633	1635	AGC	1935	1937	AGC	161;161;159	A;G;C,T	150;152;146,1	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	4192	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2385	175.0	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1953	1955	CCG	136;141;140	C,G;C;G	102,8;107;109	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5518	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3076	178.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1668	1670	CCG	205;204;203	C;C;G	183;186;181	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2112	porA	1146	1146	99.91	porA.l6.c4.ctg.1	1740	120.9	0	.	p	.	0	M83fs	FSHIFT	247	247	A	514	514	C	185	C	166	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2804	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1709	163.1	0	.	p	.	0	G210R	NONSYN	628	630	GGA	909	911	AGA	235;233;234	A;G;A	225;222;226	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2804	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1709	163.1	0	.	p	.	0	S217G	NONSYN	649	651	AGT	930	932	GGT	258;256;256	G,T;G;T	244,1;242;242	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2804	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1709	163.1	1	SNP	p	G120K	1	.	.	358	360	AAG	639	641	AAG	230;230;230	A;A;G,A	210;213;213,1	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2804	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1709	163.1	1	SNP	p	N121D	0	.	.	361	363	AAC	642	644	AAC	232;234;230	A;A;C	216;219;216	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	539	2804	porB1b	1038	1038	99.81	porB1b.l15.c4.ctg.1	1709	163.1	1	SNP	p	A121N	1	.	.	361	363	AAC	642	644	AAC	232;234;230	A;A;C	216;219;216	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	10376	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4848	213.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1092	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1082	100.7	1	SNP	p	V57M	1	.	.	169	171	ATG	575	577	ATG	202;202;203	A;T,C;G	193;191,1;194	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
